Status:
WITHDRAWN
Photoscreening for Retinoblastoma
Lead Sponsor:
Phoenix Children's Hospital
Conditions:
Retinoblastoma
Eligibility:
All Genders
Up to 10 years
Phase:
NA
Brief Summary
Retinoblastoma is the most common pediatric eye malignancy and manifests between 1 and 5 years of age. The tumor is most often diagnosed by leukocoria ( white reflex in the pupil). There is often a si...
Eligibility Criteria
Inclusion
- Age birth to 10 years
- Informed consent given by parent or legal guardian
Exclusion
- None
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04344652
Start Date
June 1 2022
End Date
June 1 2022
Last Update
September 26 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.